These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 7579559)
1. Inhibition of colon cancer cell proliferation by antisense oligonucleotides targeting the messenger RNA of the Ki-ras gene. Sakakura C; Hagiwara A; Tsujimoto H; Ozaki K; Sakakibara T; Oyama T; Ogaki M; Imanishi T; Yamazaki J; Takahashi T Anticancer Drugs; 1995 Aug; 6(4):553-61. PubMed ID: 7579559 [TBL] [Abstract][Full Text] [Related]
2. Quercetin inhibits p21-RAS expression in human colon cancer cell lines and in primary colorectal tumors. Ranelletti FO; Maggiano N; Serra FG; Ricci R; Larocca LM; Lanza P; Scambia G; Fattorossi A; Capelli A; Piantelli M Int J Cancer; 2000 Feb; 85(3):438-45. PubMed ID: 10652438 [TBL] [Abstract][Full Text] [Related]
3. Antisense oligonucleotides demonstrate a dominant role of c-Ki-RAS proteins in regulating the proliferation of diploid human fibroblasts. Chen G; Oh S; Monia BP; Stacey DW J Biol Chem; 1996 Nov; 271(45):28259-65. PubMed ID: 8910444 [TBL] [Abstract][Full Text] [Related]
4. Induction of apoptosis in small-cell lung cancer cells by an antisense oligodeoxynucleotide targeting the Bcl-2 coding sequence. Ziegler A; Luedke GH; Fabbro D; Altmann KH; Stahel RA; Zangemeister-Wittke U J Natl Cancer Inst; 1997 Jul; 89(14):1027-36. PubMed ID: 9230884 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of gastric cancer cell proliferation by antisense oligonucleotides targeting the messenger RNA encoding proliferating cell nuclear antigen. Sakakura C; Hagiwara A; Tsujimoto H; Ozaki K; Sakakibara T; Oyama T; Ogaki M; Takahashi T Br J Cancer; 1994 Dec; 70(6):1060-6. PubMed ID: 7981055 [TBL] [Abstract][Full Text] [Related]
6. Antisense oligonucleotides adsorbed to polyalkylcyanoacrylate nanoparticles specifically inhibit mutated Ha-ras-mediated cell proliferation and tumorigenicity in nude mice. Schwab G; Chavany C; Duroux I; Goubin G; Lebeau J; Hélène C; Saison-Behmoaras T Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10460-4. PubMed ID: 7937975 [TBL] [Abstract][Full Text] [Related]
7. Antisense treatment directed against mutated Ki-ras in human colorectal adenocarcinoma. Andreyev HJ; Ross PJ; Cunningham D; Clarke PA Gut; 2001 Feb; 48(2):230-7. PubMed ID: 11156646 [TBL] [Abstract][Full Text] [Related]
8. Growth inhibition of human pancreatic cancer cell lines by anti-sense oligonucleotides specific to mutated K-ras genes. Kita K; Saito S; Morioka CY; Watanabe A Int J Cancer; 1999 Feb; 80(4):553-8. PubMed ID: 9935156 [TBL] [Abstract][Full Text] [Related]
9. [Oligonucleotides complementary to the mRNA of the c-HA-ras gene suppress human cell proliferation in culture]. Debus N; Griaznov SM; Berdichevskiĭ FB Dokl Akad Nauk SSSR; 1990; 313(2):491-4. PubMed ID: 2289400 [No Abstract] [Full Text] [Related]
10. Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cells. Spänkuch-Schmitt B; Wolf G; Solbach C; Loibl S; Knecht R; Stegmüller M; von Minckwitz G; Kaufmann M; Strebhardt K Oncogene; 2002 May; 21(20):3162-71. PubMed ID: 12082631 [TBL] [Abstract][Full Text] [Related]
11. Activity of a novel bcl-2/bcl-xL-bispecific antisense oligonucleotide against tumors of diverse histologic origins. Gautschi O; Tschopp S; Olie RA; Leech SH; Simões-Wüst AP; Ziegler A; Baumann B; Odermatt B; Hall J; Stahel RA; Zangemeister-Wittke U J Natl Cancer Inst; 2001 Mar; 93(6):463-71. PubMed ID: 11259472 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of Kirsten-ras expression in human colorectal cancer using rationally selected Kirsten-ras antisense oligonucleotides. Ross PJ; George M; Cunningham D; DiStefano F; Andreyev HJ; Workman P; Clarke PA Mol Cancer Ther; 2001 Nov; 1(1):29-41. PubMed ID: 12467236 [TBL] [Abstract][Full Text] [Related]
13. [The inhibitory effect of antisense oligodeoxynucleotides on the growth of human pancreatic adenocarcinoma cell lines]. Liu TH Zhonghua Bing Li Xue Za Zhi; 1993 Feb; 22(1):25-9. PubMed ID: 8330327 [TBL] [Abstract][Full Text] [Related]
14. Transcriptional targets of hepatocyte growth factor signaling and Ki-ras oncogene activation in colorectal cancer. Seiden-Long IM; Brown KR; Shih W; Wigle DA; Radulovich N; Jurisica I; Tsao MS Oncogene; 2006 Jan; 25(1):91-102. PubMed ID: 16158056 [TBL] [Abstract][Full Text] [Related]
15. The chemopreventive agent alpha-difluoromethylornithine blocks Ki-ras-dependent tumor formation and specific gene expression in Caco-2 cells. Ignatenko NA; Zhang H; Watts GS; Skovan BA; Stringer DE; Gerner EW Mol Carcinog; 2004 Apr; 39(4):221-33. PubMed ID: 15057874 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of anchorage-independent growth of ras-transformed cells on polyHEMA surface by antisense oligodeoxynucleotides directed against K-ras. Kawada M; Fukazawa H; Mizuno S; Uehara Y Biochem Biophys Res Commun; 1997 Feb; 231(3):735-7. PubMed ID: 9070883 [TBL] [Abstract][Full Text] [Related]
17. Effects of SCH 59228, an orally bioavailable farnesyl protein transferase inhibitor, on the growth of oncogene-transformed fibroblasts and a human colon carcinoma xenograft in nude mice. Liu M; Bryant MS; Chen J; Lee S; Yaremko B; Li Z; Dell J; Lipari P; Malkowski M; Prioli N; Rossman RR; Korfmacher WA; Nomeir AA; Lin CC; Mallams AK; Doll RJ; Catino JJ; Girijavallabhan VM; Kirschmeier P; Bishop WR Cancer Chemother Pharmacol; 1999; 43(1):50-8. PubMed ID: 9923541 [TBL] [Abstract][Full Text] [Related]
18. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells. Okumura K; Shirasawa S; Nishioka M; Sasazuki T Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756 [TBL] [Abstract][Full Text] [Related]
19. Use of c-myb antisense oligonucleotides to increase the sensitivity of human colon cancer cells to cisplatin. Funato T; Satou J; Kozawa K; Fujimaki S; Miura T; Kaku M Oncol Rep; 2001; 8(4):807-10. PubMed ID: 11410788 [TBL] [Abstract][Full Text] [Related]
20. Antisense oligonucleotides specific to mutated K-ras genes inhibit invasiveness of human pancreatic cancer cell lines. Nakada Y; Saito S; Ohzawa K; Morioka CY; Kita K; Minemura M; Takahara T; Watanabe A Pancreatology; 2001; 1(4):314-9. PubMed ID: 12120210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]